[BCG vaccine immunotherapy after radical operations for lung cancer].
An investigation of immune reactivity to BCG vaccination was performed in 48 patients with lung cancer according to the Mantoux test. It was found that high immune reaction was noted in the group with 5-year survival and course without recurrences, the reaction growing after revaccinations. In patients with 2-year survival the reaction to vaccination was negative or weakly pronounced. A conclusion is made that the immune therapy facilitates improvement of long-term results of surgical treatment of patients with lung cancer.
Repin
Iu M
IuM
D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D008175:Lung Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011013:Pneumonectomy; D011182:Postoperative Care / Q000379:methods*
D001500:BCG Vaccine
Immunoterapiia vaktsinoĭ BTsZh posle radikal'nykh operatsiĭ po povodu raka legkikh.